By Rick Nauert
PhD Senior News Editor
Reviewed by John M. Grohol, Psy.D. on June 4, 2009
Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine.
Mary Gerend, assistant professor of medical humanities and social sciences at Florida State University School of Medicine, and Jessica Barley, a 2008 Florida State psychology graduate who based her honors thesis on the study, found that men are no more likely to want the vaccination just because they can help protect their female sexual partners.
An HPV vaccine for women has been available since 2006, and a vaccine for men is likely to be approved in the near future.
Link
Tagged as:
health,
hpv
By Maggie Fox, Health and Science Editor
WASHINGTON, Nov 13 (Reuters) – A vaccine designed to protect women and girls from cervical cancer caused by a wart virus may protect men, too, maker Merck and Co (MRK.N: Quote, Profile, Research, Stock Buzz) reported on Thursday.
The Gardasil vaccine was 90 percent effective in preventing lesions, mostly sexually transmitted warts, caused by the virus in men, Anna Giuliano of the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida, and colleagues found.
It was about 45 percent effective in preventing infection with the four strains of HPV that it targets.
Full story
Tagged as:
health,
hpv,
Merck
By Shari Roan, Times Staff Writer
With human papillomavirus, girls and women have been getting all the attention.
Parents across the nation have rushed to have their daughters vaccinated against the virus. States are wrestling with whether to require that adolescents get the vaccine. And recent research found that many more girls and women are infected with human papillomavirus than was previously thought — more than one-quarter of females ages 14 to 59.
Now the attention is turning to boys and men.
As many as 60% of men ages 18 to 70 are infected with HPV, according to data not yet published, raising the question of whether the new vaccine will be effective in reducing diseases linked to the virus unless men, not just women, are immunized.
Several studies are underway to better understand the virus in males and whether the new HPV vaccine, Gardasil, also will work for them. As researchers already know and as the new data confirms, HPV is not just a women’s issue. (more...)
Tagged as:
r,
tes,
The Marketplace
By Lindsey Tanner, Associated Press
CHICAGO — One in four U.S. women ages 14 to 59 is infected with the sexually transmitted virus that in some forms can cause cervical cancer, according to the first broad national estimate.
The figure is mostly in line with previous assessments. The highest prevalence — nearly 45% — was found in young women within the age range recommended for a new virus-fighting vaccine, according to a report from the federal Centers for Disease Control and Prevention.
Researchers have estimated that 20 million Americans have some form of HPV. The study concluded that 26.8% of U.S. women are infected, a figure that is comparable to earlier estimates using smaller groups.
“We expected the prevalence of any HPV infection would be high and that’s what we found,” said CDC researcher Dr. Eileen Dunne, the study’s lead author. (more…)
Tagged as:
r,
sex,
tes,
The Marketplace
Gallery Carre
